• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Common and rare variants in complement genes as biomarkers of COVID-19 infection and severity. A lesson to learn for emerging patho

tetano

Editor, Senior Moderator
Front Immunol


. 2026 Jun 11:17:1829115.
doi: 10.3389/fimmu.2026.1829115. eCollection 2026.
Common and rare variants in complement genes as biomarkers of COVID-19 infection and severity. A lesson to learn for emerging pathogens

María Eugenia De La Morena-Barrio[SUP] 1 2 [/SUP], Ana Van Den Rym[SUP] 3 4 5 [/SUP], Olga Escorial Sanz[SUP] 6 [/SUP], Fernando Corvillo[SUP] 7 [/SUP], Rosario García-Sánchez[SUP] 7 [/SUP], Laura González-Sánchez[SUP] 2 7 [/SUP], Adrián Muñoz-Barrera[SUP] 8 [/SUP], Rafaela González-Montelongo[SUP] 8 [/SUP], José Miguel Lorenzo-Salazar[SUP] 8 [/SUP], Carlos Flores[SUP] 8 9 10 11 [/SUP], Ana de Andrés-Martín[SUP] 12 [/SUP], Carlos Rodríguez-Gallego[SUP] 10 11 13 14 15 [/SUP], Luis Allende[SUP] 16 [/SUP], Laia Alsina[SUP] 17 18 19 [/SUP], Silvia Sánchez-Ramón[SUP] 20 [/SUP], Eduardo López-Collazo[SUP] 5 21 [/SUP], Margarita López-Trascasa[SUP] 7 22 [/SUP], Pilar Sánchez-Corral[SUP] 2 7 [/SUP], Rebeca Pérez de Diego[SUP] 4 5 10 [/SUP], Javier Corral de la Calle[SUP] 1 2 [/SUP], Alberto López-Lera[SUP] 2 7 [/SUP]


Affiliations
Abstract

Introduction: The first wave of Coronavirus disease 2019 (COVID-19), driven by the global emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), severely affected Spain with high infection and mortality rates across the country. Although numerous common and rare genetic variants affecting immune-related pathways have been associated with susceptibility to infection and severe disease, the contribution of complement system remains comparatively understudied.
Methods: In this work, we analyzed the frequencies and severity associations of complotype-related common polymorphisms and rare complement variants in whole-exome sequencing data from a Spanish cohort accounting for 154 adults hospitalized due to severe COVID-19.
Results: Our results indicate that the CFHR4 rs7417769 (p.N209S) and CFH rs1061170 (p. Y402H) common polymorphisms are significantly associated with protection against acute respiratory distress syndrome (ARDS), while the C3 rs2230199 (p.R102G) and MASP2 rs7255087 (p.D120G) polymorphisms respectively correlated with low and high C3 levels. The marked over-representation of the C1R rs117402032 and C8A rs143523574 polymorphisms and increased frequency of heterozygous carriers of alleles previously associated with low FCN2 and FCN3 levels, suggest a link beween defective complement activation and increased rates of SARS-CoV-2 infection and support a pivotal role for the lectin pathway in the pathogenesis of COVID-19.
Discussion: Together, these results demonstrate that common variants in complement genes modulate susceptibility to severe COVID-19 and its clinical complications. They also identify promising, testable genetic biomarkers with potential utility not only for SARS-CoV-2, but also for preparedness against future emerging infectious threats.

Keywords: ARDS (acute respiratory disease syndrome); COVID- 19; complement system; genetic variation; innate immunity.

 
Back
Top